EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Comparative effectiveness of plant-derived compounds in keloid management: a review

Arya Tjipta Prananda, Sony Eka Nugraha, Putri Cahaya Situmorang, Rony Abdi Syahputra

Frontiers in Pharmacology · 16.07.2025 · 16

DOI: 10.3389/fphar.2025.1576851 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.07.2025. Verfasst von Arya Tjipta Prananda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keloids are a challenging dermatological condition characterized by excessive scar formation beyond the original wound site, high recurrence rates, and limited treatment efficacy. Current therapies, such as corticosteroids, surgery, and radiotherapy, often yield suboptimal outcomes and adverse effects. This review evaluates the potential of plant-derived metabolites as safer and more effective alternatives for keloid management. Preclinical and clinical studies demonstrate that compounds like curcumin, epigallocatechin gallate (EGCG), and asiaticoside exhibit anti-fibrotic, anti-inflammatory, and antioxidant properties by modulating key pathways (e.g., TGF-β/Smad, NF-κB, and oxidative stress). Espite promising preclinical and early clinical findings, critical challenges hinder the clinical translation of these metabolites. These include poor and variable bioavailability, inconsistencies in extract standardization, and a paucity of large-scale, rigorously designed trials. Moreover, some metabolites may yield conflicting results or exhibit off-target effects in in vitro systems, necessitating caution in interpreting their true therapeutic potential. Future research should focus on optimizing drug delivery systems, conducting large-scale trials, and integrating personalized medicine approaches. Plant-derived metabolites represent a multi-targeted therapeutic strategy with the potential to address unmet needs in keloid treatment.

Schlagwörter

Stichwörter der Autor:innen

anti-fibrotic therapybioavailability challengeskeloid managementpersonalized medicineplant-derived metabolites

Autor:innen und Institutionen

  • Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.
  • Study Program of Biology, Faculty of Mathematic and Natural Science, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.

Zitieren

APA

Prananda, A. T., Nugraha, S. E., Situmorang, P. C., & Syahputra, R. A. (2025). Comparative effectiveness of plant-derived compounds in keloid management: a review. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1576851

Vancouver

Prananda AT, Nugraha SE, Situmorang PC, Syahputra RA. Comparative effectiveness of plant-derived compounds in keloid management: a review. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1576851

BibTeX
@article{Prananda2025,
  author = {Prananda, Arya Tjipta and Nugraha, Sony Eka and Situmorang, Putri Cahaya and Syahputra, Rony Abdi},
  title = {Comparative effectiveness of plant-derived compounds in keloid management: a review},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1576851}
}
Kostenlos starten →